GGrantIndex
Sort

166,118 grants matching stem cells

Granulocyte-Macrophage Colony Stimulated Factor (GM-CSF) in Peripheral Arterial Disease

$743,039
Arshed A Quyyumi · Emory University · R33 · FY2020 · HL

Epithelial layer jamming in breast cancer cell migration

$743,035
Jeffrey J Fredberg · Harvard School Of Public Health · U01 · FY2017 · CA

Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis

$742,984
Mary Cm Weiser-Evans · University Of Colorado Denver · R01 · FY2024 · HL

Base-Edited Hematopoietic Stem and Progenitor Cells To Enable Safe Use Of Highly Potent CD33-Targeted Radioimmunotherapy

$742,957
Roland Bruno Walter · Fred Hutchinson Cancer Center · R01 · FY2022 · CA

Transcriptomic single-cell profiling in breathing-specific parabrachial mu-opioid receptor neurons

$742,953
Sung Han · Salk Institute For Biological Studies · R01 · FY2023 · DA

Transcriptomic single-cell profiling in breathing-specific parabrachial mu-opioid receptor neurons

$742,953
Sung Han · Salk Institute For Biological Studies · R01 · FY2022 · DA

Improving cell fate conversion by tracking cells and RNA over time and space

$742,938
Kun Zhang · University Of California, San Diego · R01 · FY2016 · HL

Improving cell fate conversion by tracking cells and RNA over time and space

$742,938
Kun Zhang · University Of California, San Diego · R01 · FY2017 · HL

Integrins and Ocular Angiogenesis

$742,895
Martin Friedlander · Scripps Research Institute, The · R01 · FY2016 · EY

PTSD and Ischemic Heart Disease Progression: A Longitudinal Twin Study

$742,879
Viola Vaccarino Vaccarino · Emory University · R01 · FY2017 · HL

Structure and Function of Flaviviruses

$742,878
Michael G Rossmann · Purdue University · R01 · FY2009 · AI

The evolution of transcription initiation mechanisms and its genetic basis

$742,875
Zhenguo Lin · Saint Louis University · · FY2020 · BIO

Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients

$742,869
Guang-Shing Cheng · Fred Hutchinson Cancer Center · R01 · FY2025 · HL

Ikaros regulation: study on hemo-lymphopoiesis

$742,864
Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2025 · HL

Characterization of the Cardiac Progenitor Cell Exosomes for Optimal Therapeutics

$742,840
Sunjay Kaushal · University Of Maryland Baltimore · R01 · FY2020 · HL

Development of Drug Delivery Technology for Stem Cell Based TMJ Regeneration

$742,838
Mo Chen · Wnt Scientific, Llc · R42 · FY2021 · DE

Clinical and Basic Science Studies in Long QT Syndrome Type 3

$742,812
Wojciech Zareba · University Of Rochester · R01 · FY2017 · HL

Northwest Genome Engineering Consortium (Component 1 of 11)

$742,804
Andrew M Scharenberg · Seattle Children'S Hospital · UL1 · FY2010 · DE

Lipoprotein (a) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease

$742,803
Thorsten M Leucker · Johns Hopkins University · R01 · FY2024 · HL

Development of marmoset models of neurodegenerative disease using embryonic stem cell-based gene-editing approaches

$742,787
Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2018 · OD

Identification of Biomarkers of Cardiotoxicity using Metabolomics of Human Pluripotent Stem Cell-Derived Cardiomyocytes

$742,776
Robert E Burrier · Stemina Biomarker Discovery, Inc. · R44 · FY2015 · GM

Cell Interactions in Development of the Mammalian Kidney

$742,752
Andrew P McMahon · University Of Southern California · R37 · FY2014 · DK

JHU Center for Neuroscience Research

$742,719
Johns Hopkins University · P30 · FY2005 · NS

Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion

$742,690
David M Spencer · Baylor College Of Medicine · U01 · FY2010 · CA

DEVELOPMET OF STEM CELL TECHNOLOGIES FOR TOXICOLOGY

$742,682
Vistagen Therapeutics, Inc. · R44 · FY2003 · GM